Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.48 |
| ▸ | MAOB | P27338 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.37 |
| ▸ | ACSL1 | P33121 | 1/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 3/20 | 0.35 |
| ▸ | HTR7 | P34969 | 1/20 | 0.35 |
| ▸ | HTR2B | P41595 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6404019 | 0.98 | MAOA (0.50) | MAOAMAOBKDM4EALDH1A1HPGD | |
| SCHEMBL8797356 | 0.97 | MAOA (0.48) | MAOAMAOBKDM4EALDH1A1HPGD | |
| SCHEMBL7613593 | 0.97 | MAOA (0.48) | MAOAMAOBKDM4EALDH1A1HPGD | |
| SCHEMBL6228093 | 0.97 | MAOA (0.48) | MAOAMAOBKDM4EALDH1A1HPGD | |
| SCHEMBL11409820 | 0.97 | MAOA (0.48) | MAOAMAOBKDM4EALDH1A1HPGD | |
| SCHEMBL6906279 | 0.97 | MAOA (0.48) | MAOAMAOBKDM4EALDH1A1HPGD | |
| SCHEMBL729661 | 0.97 | MAOA (0.48) | MAOAMAOBKDM4EALDH1A1HPGD | |
| SCHEMBL2974202 | 0.97 | MAOA (0.48) | MAOAMAOBKDM4EALDH1A1HPGD | |
| SCHEMBL5050436 | 0.97 | MAOA (0.48) | MAOAMAOBKDM4EALDH1A1HPGD | |
| SCHEMBL221841 | 0.97 | MAOA (0.48) | MAOAMAOBKDM4EALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5068375-A | Substituted noble metal xanthates | EXXON RESEARCH & ENGINEERING COMPANY (US) | 1991-11-26 | — | — | US | claimed |
| US-8435966-B2 | Associations of xanthogenates and cyclodextrins, and their use | BIOSPHINGS AG (DE) | 2013-05-07 | — | — | US | disclosed |
| US-20100240606-A1 | ASSOCIATIONS OF XANTHOGENATES AND CYCLODEXTRINS, AND THEIR USE | BIOSPHINGS AG (DE) | 2010-09-23 | — | — | US | disclosed |
| EP-2001840-A1 | ASSOCIATIONS OF XANTHOGENATES AND CYCLODEXTRINS, AND THEIR USE | BioSphings AG (DE) | 2008-12-17 | — | — | EP | disclosed |
| WO-2007112828-A1 | ASSOCIATIONS OF XANTHOGENATES AND CYCLODEXTRINS, AND THEIR USE | BIOSPHINGS AG (DE) | 2007-10-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100240606-A1 | ASSOCIATIONS OF XANTHOGENATES AND CYCLODEXTRINS, AND THEIR USE | HLA-DRB1, CXCR3, ANTXR2 | MAOA 3881/4885MAOB 4358/4885KDM4E 3436/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.